Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAHLIA phase II trial of intravenous danirixin plus oseltamivir in hospitalized adults with influenza
NL-OMON43171Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing Danirixin plus oseltamivir with Placebo to danirixin plus oseltamivir (2 arms). Primary endpoint: Time to clinical response. Planned start Nov 2016; status: withdrawn.
02
Drugs
danirixinoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON43171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43171.